T-cell function is dependent on store-operated Ca 21 influx that is activated by the stromal interaction molecules (STIM) 1 and 2. We show that mice with T-cell-specific deletion of STIM1 or STIM2 are protected from EAE, a mouse model of multiple sclerosis (MS). While STIM1-and STIM2-deficient T cells could be successfully primed by autoantigen, they failed to produce the proinflammatory cytokines IL-17 and IFN-c. STIM1-deficient T cells showed reduced expression of IL-23R, required for Th17 cell homeostasis, and had impaired chemokine-dependent T-cell migration caused by a lack of chemokine-induced Ca 21 influx. Autoantigen-specific STIM1-or STIM2-deficient T cells failed to expand and accumulate in the CNS and lymph nodes following adoptive transfer to passively induce EAE, suggesting that autoantigen-specific restimulation or homeostasis of STIM1-and STIM2-deficient T cells are impaired. Combined deletion of both STIM1 and STIM2, previously shown to impair Treg development and function, completely protected mice from EAE. This indicates that, in the absence of Ca 21 influx, autoreactive T cells are severely dysfunctional rendering Treg dispensable for the prevention of CNS inflammation. Our findings demonstrate that both STIM1 and STIM2 are critical for T-cell function and autoimmunity in vivo.
Introduction
Multiple sclerosis (MS) is an autoimmune disease characterized by focal demyelination of the CNS. MS plaques are characterized by inflammatory infiltrates of autoreactive T cells and macrophages. The pathophysiology of disease has been studied extensively in EAE, an animal model of MS, which is induced by immunization of mice or rats with myelin self antigens such as myelin oligodendrocyte glycoprotein (MOG) or adoptive transfer of encephalitogenic T cells [1] . CD4
1 Th1 cells secreting IFN-g were long considered to be the predominant disease inducing T-cell subset in EAE. This view has been challenged by the finding that Ifng-deficient mice showed more severe EAE than WT littermates [2] [3] [4] . More recently, Th17 cells have emerged as an important encephalitogenic T-cell subset causing CNS inflammation based on evidence from animal models and patients with MS [5] [6] [7] [8] .
Th17 cells produce the pro-inflammatory cytokines IL-17A, IL-17F and IL-22 [9] and mice lacking IL-17 expression were partially resistant to the induction of EAE [10] . IL-17 levels were increased in cells isolated from MS lesions [11] and in the cerebrospinal fluid of MS patients [12, 13] . IL-17 secreted by Th17 cells induces the production of proinflammatory cytokines and chemokines by a number of cells such as fibroblasts, endothelial cells, epithelial cells and macrophages [7] resulting in the recruitment of, for instance, neutrophils and monocytes [14] and disruption of the blood-brain barrier [13] . Differentiation of Th17 cells from naïve CD4
1 T cells depends on a number of molecules including the transcription factor RORgt, which functions as the master regulator of Th17 differentiation. Mucosal T cells from RORgt-deficient mice failed to produce IL-17 and to induce colitis indicating that RORgt is critical for the differentiation of autoreactive Th17 cells [15, 16] . In addition, IL-6 induces the production of IL-21 and thereby expression of IL-23 receptor. The interaction of IL-23 with IL-23R is thought to be important for terminal Th17 differentiation and homeostasis [5, 17, 18] . Activation of T cells requires Ca 21 influx, which results in expression of many cytokine and chemokine genes [19] . Ca stores following antigen binding to the TCR in a process termed store-operated Ca 21 entry (SOCE) [20] . ORAI1 is the pore forming subunit of the CRAC channel, which is activated by stromal interaction molecules (STIM) 1 and 2, single transmembrane proteins located in the ER membrane. Following depletion of ER calcium stores, Ca 21 dissociates from STIM1 and STIM2 resulting in a conformational change in the N-termini of these proteins, their translocation to the plasma membrane and activation of ORAI1 CRAC channels [21] . ORAI1, STIM1 and STIM2 were shown to be critical for CRAC channel function and SOCE [22] . T cells of mice lacking Stim1 or Orai1 show severe defects in SOCE and production of IL-2, IL-4 and IFN-g [23, 24] consistent with a similar lack of cytokine gene expression in immunodeficient patients with mutations in ORAI1 or STIM1 [22, 25, 26] . STIM2 is involved predominantly in maintaining basal cytoplasmic Ca 21 levels [27] and is necessary to sustain SOCE for several hours following TCR stimulation [24] . Accordingly, murine T cells lacking STIM2 show impaired cytokine gene expression [24] but the role of STIM2 in T-cell function and immune responses in vivo has not been demonstrated yet. Combined deletion of both Stim1 and Stim2 results in impaired development and function of regulatory T cells and is associated with myelolymphoproliferative disease in mice [24] . In this study, we investigated whether STIM1 and STIM2 in T cells are required for induction of T-cell-mediated autoimmune disease. Mice with T-cell-specific deletion of Stim1 or both Stim1 and Stim2 were protected from induction of EAE, whereas lack of Stim2 significantly attenuated disease severity. Resistance to EAE in Stim1 fl/fl Cd4-Cre and Stim2 fl/fl Cd4-Cre mice was characterized by severely impaired effector T-cell-functions such as production of proinflammatory cytokines IL-17 and IFN-g. STIM1 and STIM2-deficient T cells failed to expand and to accumulate in the CNS and lymph nodes, a defect that is associated with impaired IL-23R expression on Th17-differentiated cells. STIM1 deficiency is associated with abolished chemokine-dependent Ca 21 signaling and reduced chemotaxis of T cells. These studies demonstrate a crucial role for STIM1, STIM2 and SOCE in the function of autoreactive T cells.
Results
Mice with T-cell-specific deletion of Stim1, Stim2 or both Stim1 and Stim2 are resistant to induction of EAE [24] . The course of disease in terms of onset and duration, however, was not altered in STIM2-deficient mice compared to WT mice. Significantly decreased severity of EAE in Stim2 fl/fl Cd4-Cre mice is in contrast to normal disease severity in Stim2 À/À mice (despite a moderate delay in EAE onset) reported recently [28] . In summary, we find that abolishing either STIM1 or STIM2 expression in T cells is sufficient to protect mice from EAE, demonstrating for the first time an important role for STIM2 in T-cell function in vivo. Notably, Stim1 fl/fl Stim2 fl/fl Cd4-Cre mice were as protected from EAE as STIM1-deficient mice with a disease incidence of 16.7% and a mean disease score of 0.08 (Fig. 1C , Table 1 ). We had shown previously that mice with T-cell-specific deletion of both STIM1 and STIM2 have severely reduced numbers and function of Treg and show a propensity to develop an autoinflammatory, myelolymphoproliferative phenotype [24] . The complete protection of these mice from EAE despite the paucity of functional Treg suggests that the lack of STIM1 and STIM2 impairs autoreactive effector T-cell functions so severely that Treg become dispensable for controlling CNS inflammation. In the following, we therefore focused our studies on mice with T-cell-specific deletion of either STIM1 or STIM2 alone, deliberately excluding the effects of impaired Treg activity in Stim1 fl/fl Stim2 fl/fl Cd4-Cre mice. Taken together, we show here that both STIM1 and STIM2 are critical for autoreactive T-cell function in vivo. , n 5 8 in A, n 5 7 in B, n 5 3 in C) mice with MOG Fig. 3A-D) . By contrast, the number of IL-17A 1 cells and the level of IL-17A expression per cell were severely reduced in STIM1-deficient T cells that were restimulated with PMA/ionomycin ( Fig. 3A and B) . A similar defect in Th17 cytokine expression was observed in T cells from Stim1 fl/fl Cd4-Cre mice at the mRNA level.
Transcript levels of IL-17A, IL-17F and IL-22 in non-stimulated cells were significantly reduced (Fig. 3E , left panels) and induction of IL-17A expression upon restimulation was strongly impaired (Fig. 3E , right panel). Th17-differentiated cells from Stim2 fl/fl Cd4-Cre mice showed a similar defect in IL-17 production that was only slightly less pronounced than that in STIM1-deficient Th17-differentiated cells ( Fig. 3C and D) . This finding is consistent with the role of STIM2 in maintaining SOCE and nuclear translocation of NFAT, which is required for expression of cytokines such as IFN-g [24] . Taken together, Th17 cytokine expression is severely compromised in the absence of either STIM1 or STIM2 even under cell culture conditions in vitro that strongly favor the development of Th17 cells.
Normal expression of RORct and RORa but reduced levels of IL-23R in STIM1-deficient Th 17 cells
To exclude that IL-17 expression was impaired because CD4 1 T cells fail to differentiate into Th17 cells in the absence of SOCE, we assessed the expression of transcription factors, cytokines and cytokine receptors that are essential for Th17 resulted in impaired IL-23-mediated STAT3 phosphorylation in STIM1-deficient Th17 cells (Fig. 4E) . Reduced IL-23R expression in STIM1-deficient T cells may interfere with Th17 cell homeostasis and expansion of IL-17-producing encephalitogenic T cells as IL-23 was shown to maintain IL-17 production in Th17 cells including encephalitogenic Th17 cells [31] .
STIM1 and STIM2 are required for expansion of encephalitogenic T cells
While the defect in Th17 cell effector function in the absence of STIM1 provides a reasonable explanation for the resistance of Stim1 fl/fl Cd4-Cre mice to EAE, it was surprising to see a complete absence of STIM1-deficient T cells in the CNS of MOG treated mice (Fig. 1D-F ) despite apparently normal priming and proliferation of STIM1-deficient T cells ( Fig. 2A and B) . IL-17 itself was shown to disrupt tight junctions between endothelial cells of the blood-brain barrier thus directly promoting infiltration of encephalitogenic T cells into the CNS [13] . Impaired IL-17 production in STIM1-deficient T cells could be responsible -at least in part -for the absence of T cells in the CNS of Stim1 of STIM1-deficient T cells in the brain and spinal cord was strongly reduced (Fig. 5C and D) . The predominance of WT T cells and paucity of STIM1-deficient T cells was, however, not specific to the CNS but was also observed in the spleen and lymph nodes (Fig. 5D) enrichment of WT T cells in both the CNS and peripheral lymphoid organs (Supporting Information Fig. 1 ). These findings suggested that STIM1-and STIM2-deficient T cells die or fail to proliferate when transferred in vivo or that they have a defect in migrating to the CNS and secondary lymphoid organs.
Excessive death of T cells lacking SOCE as a cause for reduced numbers of STIM1-deficient T cells in the CNS or lymphoid organs is unlikely as ratios of CD45.1 1 WT and CD45.2 1 STIM1-deficient T cells remained close to a 1:1 ratio for at least 8 days after cell transfer (Fig. 5E , left and right panels). Absolute numbers of STIM1-deficient cells in the CNS increased moderately during this time period at a rate that was only slightly reduced compared to WT T cells (Fig. 5E, middle panel) . By contrast, 14 days after transfer, absolute numbers of CD45.1 1 WT T cells in the CNS had increased dramatically whereas numbers of CD45.2 1 STIM1-deficient T cells remained constant (Fig. 5E , middle panel) suggesting that T cells lacking SOCE fail to properly expand in vivo or migrate to the CNS and lymphoid organs. The reduced number of STIM1-deficient T cells 14 days after transfer is unlikely to be due to a general proliferation defect or excessive cell death. T cells lacking STIM1 proliferate -at least over a short period of time (3 days) -as well or better than WT T cells in vitro ( Fig. 2A and B) and in vivo when adoptively transferred into an allogeneic recipient (Supporting Information  Fig. 2 ). STIM1-deficient T cells differentiated under Th17 conditions for 8 days in vitro are viable but fail to expand compared to WT control cells (Supporting Information Fig. 3 ). This defect is Th17 specific and is not observed in STIM1-deficient Th1 cells A specific defect in the expansion of STIM1-deficient Th17 cells in vitro (Supporting Information Fig. 3C ) and in vivo (Fig. 5E ) may be related to the reduced IL-23R expression we observed in Th17-differentiated cells as IL-23 is critical for Th17 homeostasis [18] .
Chemokine-receptor-mediated Ca 21 influx and migration are impaired in STIM1-deficient T cells
To determine whether STIM1-deficient T cells may have a defect in their ability to migrate, we investigated chemokine-dependent Ca 21 influx and chemotaxis. Chemokine binding to G-protein coupled chemokine receptors activates PLCb resulting in production of inositol 1,4,5-triphosphate. T cells from PLCb2b3 À/À mice were shown to have impaired Ca 21 influx and a defect in migration when stimulated with the CXCR4 ligand SDF1a (CXCL12) [32] . We find that Ca 21 influx in response to chemokine stimulation is store-operated and depends on STIM1 as T cells from Stim1 fl/fl Cd4-Cre mice lack CXCL11 and CCL19-mediated Ca 21 influx in contrast to WT T cells ( Fig. 6A and B) despite normal expression levels of the chemokine receptors CXCR3 and CCR7 (Supporting Information Fig. 4 ). Impaired chemokine induced SOCE in STIM1-deficient T cells is associated with a moderate defect in chemotaxis in response to CXCL11 and CCL19 stimulation (Fig. 6C) . A similar migration defect of STIM1-deficient T cells was observed in response to CCL20, which binds to the chemokine receptor CCR6. CCR6 is predominantly expressed on Th17 cells. Infiltration of encephalitogenic T cells into the CNS during EAE has recently been suggested to depend on CCR6 because mice lacking expression of CCR6 were protected from EAE and lacked T cells in the CNS [33] [34] [35] . We find that CCL20-dependent migration of Th17-differentiated cells lacking STIM1 was impaired compared to WT T cells (Fig. 6D, left panel) . In addition, expression levels of CCR6 were reduced on Th17-differentiated cells from Stim1 fl/fl Cd4-Cre mice compared to WT controls (Fig. 6E) . When chemotaxis was compared in CCR6 1 T cells only, STIM1-deficient CCR6 1 T cells showed moderately reduced chemotaxis compared to CCR6 1 WT T cells (Fig. 6D, right panel) , suggesting that impaired CCL20-dependent chemotaxis of STIM1-deficient T cells is due to both reduced CCR6 expression and partially impaired signaling through CCR6. As PLCb activation and Ca 21 influx are signaling mechanisms common to all chemokine receptors, these findings indicate that SOCE is required for chemokine signaling and migration of T cells in response to a wide range of chemokine signals. Abolished SOCE in the absence of STIM1 is likely to contribute to the low numbers of T cells in the CNS and lymphoid organs of Stim1 fl/fl Cd4-Cre mice.
Discussion
In this study, we show that two essential regulators of SOCE in T cells, STIM1 and STIM2, are required for the function of autoreactive T cells and their ability to induce EAE. T-cell-specific deletion of STIM1 renders mice almost completely resistant to EAE; a similar albeit less complete protection was observed in mice lacking STIM2 in T cells. An important role for STIM1 and STIM2 in EAE was recently reported in a study demonstrating that Stim1 À/À bone marrow chimeric mice are resistant to EAE, whereas severity of EAE in complete Stim2 À/À mice was comparable to control mice despite moderately delayed disease onset [28] . The latter finding is in contrast to a more pronounced protective effect we observed in mice with T-cell-specific deletion of STIM2. Given the use of bone marrow chimeric mice in the latter study, the lack of STIM proteins in a variety of immune cell types including T cells and macrophages can potentially contribute to the protection from EAE despite the fact that dendritic cells appeared to function normally [28] . We here propose that T-cell-specific deletion of STIM1 or STIM2 is sufficient to protect mice from EAE. We show that STIM proteins are required for several aspects of effector T-cell function during EAE including (i) production of proinflammatory cytokines, Fig. 2A) [24, 36, 37] and allogeneic stimulation in vivo (Supporting Information Fig. 3 ). By contrast, cytokine gene expression in effector T cells is likely to require stronger, more sustained Ca 21 signals provided by SOCE. Importantly, even when STIM1-and STIM2-deficient T cells were biased to differentiate into Th17 cells in the presence of IL-6 and TGF-b in vitro they failed to produce IL-17 ( Fig. 3A-D) . The defect in IL-17 production in T cells from Stim1
CD4Cre mice is not specific to Th17 cytokines as STIM1-deficient T cells also lacked expression of IFN-g, IL-2 and IL-4 ( Fig. 2D ) [24] . In Th1 and Th2 cells, Ca 21 influx is required for activation of the transcription factor NFAT, which interacts with T-bet and GATA-3 to induce production of IFN-g and IL-4, respectively (reviewed in [38] ). NFAT has recently been demonstrated to be able to mediate IL-17A expression, presumably by binding to a newly identified NFAT binding site in the IL-17A promoter [39] . Lack of IL-17 and IFN-g production in STIM1-deficient T cells does not seem to result from impaired initial Th cell differentiation as the expression of lineage specific transcription factors such as RORgt, RORa and T-bet was normal in STIM1-deficient Th17 and Th1 cells, respectively. By contrast, we observed reduced expression of IL-23R in Th17-differentiated cells from STIM1-deficient mice. IL-23 was shown to maintain IL-17 production in Th17 cells including encephalitogenic Th17 cells [31] , to be required for terminal Th17 differentiation and to act as a survival factor for Th17 cells [5, 17, 18] . Mice lacking the p19 subunit of IL-23 or IL-23R showed reduced IL-17 production and were resistant to induction of EAE [17, 40] . We speculate that reduced expression of IL-23R in STIM1-deficient T cells may interfere with homeostasis of Th17 cells. This could explain why STIM1-deficient encephalitogenic T cells from MOG immunized mice fail to expand in vivo compared to WT T cells when adoptively transferred to Rag2 À/À mice ( Fig. 5E ) and why Th17 but not Th1 cells from Stim1 fl/fl CD4Cre mice fail to proliferate in vitro (Supporting Information Fig. 3C ). Strongly impaired production of both IL-17 and IFN-g in T cells from STIM1 and STIM2-deficient mice is likely to contribute to their resistance to EAE. Although the role of Th1 cells in the pathophysiology of murine EAE has been called into question after the finding that Ifng À/À mice are susceptible to EAE [2, 41, 42] , recent data suggest that both Th1 and Th17 cell contribute to different aspects of EAE pathogenesis [43] [44] [45] . It therefore seems likely that the combined lack of both IFN-g and IL-17A production in STIM-deficient T cells has a synergistic effect in protecting animals from autoimmune CNS inflammation. Finally, a defect in chemokine-dependent migration in STIM1-deficient T cells may contribute to protection against EAE. Chemokine signaling has been implicated in the pathogenesis of EAE as several chemokine-receptor-deficient mice including Ccr2 À/À , Ccr6 À/À and Ccr7 À/À mice are protected from EAE [33, [46] [47] [48] . Resistance to EAE in some of these mice was attributed to altered T-cell priming and generation of proinflammatory T cells in the periphery [34, 48] while impaired T-cell infiltration into the CNS is responsible for resistance to EAE in Ccr6 À/À mice despite normal differentiation into Th17 cells in the periphery [33] . We observed a partial defect in the expression of CCR6 in Th17-differentiated STIM1-deficient cells in vitro and impaired T-cell migration toward the CCR6 ligand CCL20. This phenotype is part of a more general defect in chemokine signaling and migration in the absence of STIM1. A role for STIM1 and STIM2 has been described for other cell types known to be important for EAE besides T cells including neurons and endothelial cells. Neurons in Stim2 À/À mice were protected from hypoxic cell death [50] and STIM1 was reported to mediate SOCE and proliferation of endothelial cells [51] . There is some evidence that Ca 21 signals in endothelial cells are involved in regulating the integrity and formation of adherens and tight junctions between endothelial cells in the lung and CNS, respectively. In the lung vasculature endothelial cells are linked predominantly by adherens junctions. Neurohumoral inflammatory mediators induce Ca 21 influx in endothelial cells and increase endothelial cell permeability and intercellular gap formation [52] . Ca 21 influx may also be implicated in the formation and maintenance of tight junctions between endothelial cells [53] . In light of these findings, it is noteworthy that mice with T-cell-specific deletion of STIM2 in our study were more protected from EAE compared to Stim2 À/À mice that lack STIM2 in all tissues including oligodendrocytes and endothelial cells [28] . Lack of STIM2 apparently does not protect oligodendrocytes -the main target of encephalitogenic T cells in EAE and MS -and neurons from cell death during EAE which is in contrast to protection of Stim2 À/À mice from hypoxemia induced neuronal death [50] . 
Histology and immunohistochemistry
Spinal cord serial sections, cut at 5 mm, were stained with hematoxylin/eosin and Luxol fast blue using standard methods. Images were acquired using a Zeiss Axioskop 40 microscope (Carl Zeiss MicroImaging, Thornwood, NY, USA) and ProgRes image capture software (JENOPTIK Optical Systems, Easthampton, MA, USA). Immunohistochemistry was performed as described [59] . Briefly, sections were incubated with biotin-conjugated rat-antimouse CD45 antibody (30-F11, BD Bioscience) and HRPconjugated streptavidin (Jackson Immunoresearch, West Grove, PA, USA). Biotin-tyramide (Perkin Elmer) was used to amplify the fluorescence signal with streptavidin-Alexa 594 (Invitrogen).
Images were acquired using a Zeiss AxioImager M1 equipped with an AxioCam MRm digital camera and analyzed using AxioVision software (Carl Zeiss MicroImaging).
T-cell isolation and stimulation
Unless otherwise indicated, CD4 1 T cells were isolated from draining lymph nodes and spleen of mice by negative selection using antibody-coated magnetic beads (Invitrogen). For cytokine measurements, CD4 1 T cells isolated from spleen and lymph nodes of MOG immunized mice were stimulated with 50 mg/mL MOG either together with irradiated (20 Gy) splenocytes from syngeneic C57BL/6 mice or 10 ng/mL IL-23 as indicated.
Th differentiation in vitro
For in vitro differentiation of CD4 1 T cells into ThN, Th1 or Th17 cells, 1 Â 10 6 negatively selected CD4 1 T cells were stimulated with 0.25 mg/mL anti-CD3 (145-2C11, eBioscience) and 1 mg/mL anti-CD28 (37.51, eBioscience) in goat-anti-hamster IgG (0.12 mg/mL, MP Biomedicals) pre-coated 6-well plates. For ThN cells, no further supplements were added; for Th1 cells, 10 ng/mL IL-12 (Peprotech) and 5 mg/mL anti-IL-4 (11B11, eBioscience) were added; for Th17 cells, 10 mg/mL anti-IFN-g (XMG1.2, eBioscience), 10 mg/mL anti-IL-4, 20 ng/mL mouse IL-6 (Peprotech, Rocky Hill, NJ, USA) and 0.5 ng/mL human TGF-b1 (Peprotech) were added. T cells were cultured for 3 days in IMDM (Cellgro, Mediatech, Manassas, VA, USA) containing 2 mM L-glutamine, 50 mM b-mercaptoethanol, 100 U/mL penicillin, 100 mg/mL streptomycin and 10% FBS. 
Intracellular cytokine measurements and flow cytometry
For cytokine analysis, T cells were stimulated with 10 nM PMA and 1 mM ionomycin for 6 h; 5 mM Brefeldin A was added during the last 2 h of stimulation. Following Fc block with anti-CD16/32 (clone 93, eBioscience) cells were incubated with FITC-conjugated anti-mouse CD4 (L3T4) and fixed/permeabilized either with 4% paraformaldehyde/0.5% saponin or commercial ''Foxp3 staining buffer'' (eBioscience). Cells were stained with the following antibodies (all from eBioscience): Alexa Fluor 647-conjugated anti-mouse IL-17A (eBioTC11-18H10.1), PE-conjugated antimouse IFN-g (XMG1.
2), APC-conjugated anti-mouse IL-2 (JES6-5H4), PE-conjugated anti-mouse IL-4 (11B11), PE-RORgt (clone AFKJS-9). For chemokine receptor analysis, cells were stained with rat anti-mouse CCR6 (Alexa Fluor 647, BD Pharmingen) and analyzed using a LSRII cytometer (BD Biosciences) and FlowJo software (Treestar, Ashland, OR, USA).
Isolation of mononuclear cells from the CNS
Mice were anesthetized with ketamin/xylazine, perfused intracardially with 1 Â PBS and sacrificed immediately. Brain and spinal cord were homogenized in 1 Â PBS, passed through a 70-mm cell strainer and mononuclear cells isolated by Percoll (Sigma) density gradient centrifugation according to the manufacturer's protocol.
STAT3 phosphorylation
Th1 and Th17 cells were differentiated for 3 days and incubated with 5 ng/mL of IL-23 (eBioscience) for 30 min at 371C in 10% CO 2 . Cells were fixed in 4% paraformaldehyde, permeabilized with 90% methanol (À201C) and washed with 1 Â PBS/1% BSA. Following Fc block with anti-CD16/32, cells were incubated with anti-mouse CD4 (L3T4, eFluor 450-conjugated, eBioscience) and anti-mouse STAT3 (pY705, clone 4/P-STAT3, PE-conjugated, BD Biosciences).
ELISA

CD4
1 cells were isolated from MOG -immunized mice and stimulated for 3 days with 50 mg/mL MOG in the presence of syngeneic irradiated (20 Gy) splenocytes. On day 3, cell culture supernatants were analyzed for IL-17A and IFN-g using Ready-SET-Go ELISA kits (eBioscience) according to manufacturer's instructions.
Migration assays
5 Â 10 5 CD41 T cells differentiated in vitro into ThN or Th17 cells were resuspended in RPMI-1640 (0.5% FBS) and added to the upper compartment of a transwell chamber (Costar, Corning). The bottom compartment contained either medium alone or medium plus CCL20 (500 ng/mL), CXCL11 (100 nM) or CCL19 (30 nM) (all from Peprotech). Cells were incubated for 2 h (CXCL11, CCL19) or 4 h (CCL20) at 371C, 5% CO 2. Cells migrated to the bottom compartment were counted directly (CXCL11, CCL19) or first stained with anti-CCR6 antibody (CCL20) and then analyzed and counted by flow cytometry. Migration rates were calculated by dividing the number of cells migrated toward the chemokine by the number of cells migrated toward medium alone.
Real-time PCR
Quantitative RT-PCR was performed as described [60] . Briefly, cDNA was synthesized with SuperScript II reverse transcriptase (Invitrogen) from 150 ng total RNA of ThN-or Th17-differentiated T cells. Gene-specific cDNAs were amplified using the Maxima SYBR Green qPCR Master Mix (Fermentas, Glen Burnie, MD, USA) and an iCycler thermocycler (BioRad). Threshold cycles for each transcript (C T ) were normalized to GAPD (DC T ). Gene expression is shown as 0.5
DCT
. Real-time PCR were performed in triplicates. Primer sequences can be found in Supporting Information.
Western blots
Western blots were performed as described [60] . Briefly, total cell lysates from Stim1 fl/fl Cd4-Cre and Ctrl (Stim1 fl/fl ) Th1 and Th17 cells were separated by SDS-PAGE, transferred to nitrocellulose membrane and incubated overnight at 41C with rabbit polyclonal anti-IL23R antibody (Millipore). Blots were reprobed with antiActin antibody (Santa Cruz) to control for equal loading. 
Statistical analysis
Statistical analysis was performed using the unpaired, two-tailed Student's t-test.
